Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phaseshift Technologies has developed and commercialized an AI-powered computational platform, Rapid Alloy Design (RAD)™, which accelerates the discovery, optimization, and evaluation of new alloys and composites. The platform enables industries to design bespoke materials with properties tailored to specific engineering needs—such as strength, thermal conductivity, corrosion resistance, or biocompatibility—at speeds up to 100× faster than traditional methods[1][2][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phaseshift Technologies.